Characterizing the prevalence of antibody-drug conjugated–induced nausea and vomiting (ADCINV) in patients with cancer.
Year: 2026
Type: conference-abstract
Source: Journal of Clinical Oncology
Authors: Ronald Chow, Daniel Zhang, Samy Kannout, Andreas Ma, Cindy Zheng, Ayden Blayne, Aaron Dou, Sumeet Talwar, Rouhi Fazelzad, Hope S. Rugo, Christina H. Ruhlmann, Hirotoshi Iihara, Mary Lou Affronti, Jennifer Rose Leigh, Florian Scotte, Lawson Eng, MASCC Antiemetic Study Group and MASCC Emerging Toxicities Study Group
Institutions: University of Toronto, Princess Margaret Cancer Centre, University of Illinois Urbana-Champaign, University Health Network, City Of Hope National Medical Center, Odense University Hospital, Gifu University Hospital, Duke University, Sunnybrook Health Science Centre, Sunnybrook Hospital, Odette Cancer Centre, Institut Gustave Roussy, Fondation Gustave Roussy
Language: English
Subfield: Surgery
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W7162694679
Cites:
Cited by:
Related to:
